Determination of olanzapine in a postmortem case

Journal of Analytical Toxicology

Volumn 22, Issue 7, 1998, Pages 605-609

  Jenkins, Amanda J ^a   Sarconi, Krista M ^a   Raaf, Heather N ^a  

^a Cuyahoga County Coroner's Office   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OLANZAPINE;

ARTICLE; CASE REPORT; CAUSE OF DEATH; DRUG BLOOD LEVEL; DRUG DETERMINATION; EXTRAPYRAMIDAL SYMPTOM; GAS CHROMATOGRAPHY; HUMAN; HUMAN CELL; HUMAN TISSUE; LIQUID LIQUID EXTRACTION; MALE; PSYCHOSIS;

EID: 0031725972     PISSN: 01464760     EISSN: None     Source Type: Journal    
DOI: 10.1093/jat/22.7.605     Document Type: Article

References (2)

1. R.W. Fuller and H.D. Snoddy. Neuroendocrine evidence for antago nism of serotonin and dopamine receptors by olanzapine (LY1770053), an antipsychotic drug candidate. Res. Comm. Chem. Path. Pharmacol. 77: 87-93 (1992).
2. J.T. Catlow, R.D. Barton, M. Clemens, T.A. Gillespie, M. Goodwin, and S.P. Swanson. Analysis of olanzapine in human plasma utilizing reversed phase high performance liquid chromatography with electrochemical detection. J. Chromatogr. Biomed. Appl. 668: 85-90 (1995).